Longfellow Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Longfellow Investment Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-200,000	Closed	-$3.59M	–	103
2017 Q4	$3.59M	Buy	+200,000	New	+$2.46M	0.87%	45

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Longfellow Investment Management's SCMP Position: Q1 2018 in Review

Longfellow Investment Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 200,000 shares — an estimated $3.59M sold.

Longfellow Investment Management first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $3.59M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Longfellow Investment Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Longfellow Investment Management sold 200,000 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $3.59M.
Longfellow Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
Longfellow Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $3.59M in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Longfellow Investment Management's 13F filing for Q1 2018, filed 11 May 2018.